Latest Multi-drug-resistant tuberculosis Stories
Global NGO's Program to Improve Health of Ukrainians Through TB Testing And Other Measures to Prevent Rapid Increase of the Disease in Ukraine - Fifth Largest TB Burden Country In the World.
A novel approach to discover the first new tuberculosis (TB) combination drug regimen cleared a major hurdle when Phase II clinical trial results found it could kill more than 99 percent of patients' TB bacteria within two weeks and could be more effective than existing treatments.
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection.
Immune Network Ltd. (IMMFF), announces the completion of a Phase II trial of a once-daily M. vaccae pill (V7) conducted by Immunitor in Ukraine.
In 2010 the World Health Organization (WHO) estimated there were 290,000 cases of multi-drug resistant tuberculosis globally. Now a new medication attempts to slash those numbers.
A joint Innovation Summit seeks to find solutions for identified barriers to treating tuberculosis. Boston, MA (PRWEB) May 17, 2012 Leading global public
- Pertaining to the surface or end opposite to the mouth in a radiate animal.